How to reconstitute semax nasal spray, step by step

Last updated 2026-07-25

What does reconstituting Semax actually mean?

Semax ships as either a pre-made nasal spray or, more often in the research-chemical market, a lyophilized (freeze-dried) powder in a small glass vial. Powder is stable and cheap to ship. It is also useless as a nasal spray until someone adds liquid back to it. Reconstitution just means dissolving that powder in a sterile liquid so it can be measured and sprayed. The original Russian formulation, developed as a synthetic ACTH(4-10) analog, was studied and manufactured as a ready-to-use intranasal solution in Russian clinical practice, not as a powder a patient mixes at home ^[1]. The powder-plus-diluent approach reflects how the compound is distributed outside that regulatory environment, not how it was studied or approved in Russia. That distinction matters for anyone reading this practically: everything below describes a compounding technique, not a clinical protocol validated in a controlled trial. Nobody has published a peer-reviewed study on home reconstitution of Semax. The mixing math is straightforward pharmacy arithmetic; the safety of the result depends entirely on what's actually in the vial, which brings up sourcing before technique.

What do you need before you start?

You need five things: the lyophilized Semax powder in its sealed vial, a sterile diluent, a syringe (typically 1 mL or 3 mL with a fine needle for drawing liquid into the vial), alcohol swabs, and an empty nasal spray bottle rated for the volume you're making (commonly 5 mL or 10 mL, sold with a metered-dose pump that delivers a fixed spray volume, often 0.1 mL per actuation). Work on a clean, wiped-down surface. Wash your hands. Swab the rubber stopper on the powder vial and the diluent vial with alcohol before every puncture, every time. This is not optional theater. A peptide solution is a good growth medium for bacteria, and you are about to spray it into your nasal mucosa, which sits close to the brain via the olfactory nerve pathway, one of the very things that makes Semax's route of administration interesting pharmacologically ^[1] and one of the reasons contamination risk is not trivial.

Which diluent should you use: bacteriostatic water, sterile water, or saline?

Bacteriostatic water (sterile water with 0.9% benzyl alcohol added as a preservative) is the standard choice for peptides that will sit around for days or weeks after mixing. The benzyl alcohol inhibits bacterial growth in the vial between uses, which matters because a multi-use nasal spray bottle gets opened dozens of times. Sterile water without a preservative works chemically but has no antimicrobial protection, so any contamination introduced during mixing or repeated use has nothing stopping it from growing. If you use plain sterile water, treat the mixed solution as short-dated and refrigerate it, using it up quickly rather than stretching it over a month. Sterile saline (0.9% sodium chloride) is used by some people because it's isotonic with nasal mucosa and may feel less irritating on the sinus lining than water-based solutions. There's no published comparison of saline versus bacteriostatic water specifically for Semax stability or nasal tolerability, so this is a comfort preference, not a documented requirement. Do not use tap water, distilled water from a non-sterile source, or anything not explicitly labeled sterile and pharmaceutical-grade. This is the single most common corner people cut, and it's the one most likely to cause a sinus infection rather than a cognitive improvement.

How much diluent do you add, and what concentration should you target?

This is pharmacy math, not guesswork, and it's worth doing on paper before you touch a syringe. Say your vial contains 30 mg of Semax powder. If you add 3 mL of bacteriostatic water, you get a concentration of 10 mg/mL, which is a 1% solution. If you add 6 mL instead, you get 5 mg/mL, a 0.5% solution. Russian clinical literature and commercial Semax products commonly reference 0.1% and 1% intranasal solutions, corresponding to 1 mg/mL and 10 mg/mL respectively ^[1]. Here's a simple reference table for a 30 mg vial:

Once you know your concentration and your spray pump's delivery volume (check the packaging; 0.1 mL per actuation is common but not universal), you can calculate how many sprays deliver your target dose. Get the concentration wrong and every dose downstream is wrong too, so this step deserves more care than the actual mixing. For a full walkthrough of dose ranges people commonly reference and how they map to sprays per day, see semax storage and shelf life for handling once mixed, and treat any dosing decision as separate from the reconstitution math itself.

What's the actual step-by-step process?

1. Swab the top of both the powder vial and the diluent vial with an alcohol wipe. Let them air dry a few seconds. 2. Draw your calculated volume of diluent into the syringe. 3. Insert the needle into the powder vial through the rubber stopper, angling toward the glass wall rather than straight down onto the powder. 4. Push the diluent in slowly, along the glass wall, not directly onto the powder. A hard direct stream can shear the peptide or just create a lot of stubborn foam. 5. Do not shake. Swirl the vial gently, or let it sit and roll it between your palms. Lyophilized peptides generally dissolve within a minute or two of gentle swirling. Shaking denatures some peptides by introducing air and mechanical stress at the liquid surface; there's no dedicated Semax stability study on this, so the cautious approach (borrowed from general peptide-handling practice) is to swirl, not shake. 6. Once fully clear (no visible particles or haze), draw the solution back into the syringe and transfer it into your nasal spray bottle. 7. Prime the pump: spray it a few times into a tissue or the sink, not your nose, until the mist looks consistent. This clears air from the pump mechanism so your first real dose isn't mostly air.

How do you know if the reconstituted solution is bad?

Look for cloudiness, visible particles, discoloration, or a change in smell before every use, more than the first. A properly mixed Semax solution should be clear and colorless. If it looks cloudy right after mixing, it may not be fully dissolved yet. Give it more time and gentle swirling. If it turns cloudy days or weeks later, that's a different problem: possible contamination or degradation, and the solution should be discarded rather than used. There is no peer-reviewed shelf-life study on reconstituted Semax specifically. General peptide-handling guidance (refrigerate after mixing, use within the window the diluent's preservative supports, avoid heat and direct light) is a reasonable default, not a documented Semax-specific finding. For a fuller breakdown of storage temperatures and how long mixed solution realistically holds up, see semax storage and shelf life.

Can you reconstitute Semax with plain tap or distilled water?

You can, technically, dissolve the powder in it. You should not. Tap water carries municipal bacteria, chlorine byproducts, and minerals that have no place in a solution you're spraying into nasal mucosa. Distilled water sold for humidifiers or steam irons is not sterile in the pharmaceutical sense and isn't produced under the same quality controls. The cost difference between tap water and a vial of USP-grade bacteriostatic water is a few dollars. That's not a place to economize. If you can't source proper bacteriostatic water or sterile saline, that's a sign to pause the whole process, not a reason to substitute.

What if the powder won't fully dissolve?

Most lyophilized peptides dissolve within a couple of minutes of gentle swirling at room temperature. If yours is stubborn, let the vial sit for 10 to 15 minutes and swirl again rather than shaking harder or adding heat. Warming a vial with your hands briefly is generally fine; deliberately heating it on a stove or in hot water is not, since heat can degrade peptide structure. If it still won't clear after that, something is off with the powder itself, possibly a filler, a different substance than labeled, or a manufacturing defect. This is a sourcing problem, not a technique problem, and it's a good reason to stop and reconsider the supplier rather than push forward with a solution you can't verify.

Why does sourcing matter as much as the mixing method?

Because the entire reconstitution process assumes the powder in the vial is actually Semax at the labeled purity, and that assumption is often untested. There is no requirement that research-chemical vendors verify content with certificates of analysis, and even where COAs are provided, they can be fabricated or run on a different batch than what shipped. In the United States, Semax is not an FDA-approved drug. You can confirm this yourself by checking Drugs@FDA, the FDA's own database of approved drug products ^[2]; Semax does not appear there. It also is not on FDA's list of bulk drug substances that compounding pharmacies may legally use under Section 503A, the list published at 21 CFR 216.23, nor on the parallel 503B list for outsourcing facilities at 21 CFR 216.24 ^{[3] [4]}. The compounding statute itself, 21 U.S.C. 353a, permits pharmacies to compound from bulk substances only under specific conditions tied to a valid prescription and substances that meet quality standards ^[5]. None of that framework covers a peptide sold as a research chemical mixed at home. That's the practical reason a provider-reviewed source matters more than a perfectly executed mixing technique. Semax Labs points readers toward a provider-reviewed nasal spray fulfilled through Tailor Made Compounding, rather than unregulated raw powder, precisely because reconstitution technique can't fix a sourcing problem. Good syringe technique on contaminated or mislabeled powder still gives you contaminated or mislabeled spray.

Does the Russian research on Semax say anything about home reconstitution?

No, and this is worth being direct about. Semax has a genuinely long clinical history in Russia, developed from ACTH(4-10) research and studied for ischemic stroke recovery, cognitive effects, and neuroprotection across dozens of published papers, many in Russian-language journals like Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova ^{[6] [6]}. A 2018 study in that journal reported on Semax efficacy across different stages of ischemic stroke treatment in Russian clinical practice ^[6]. That body of work describes Semax as a manufactured, quality-controlled pharmaceutical product administered intranasally in clinical or research settings, not something patients reconstituted from powder at home ^{[1] [6]}. Russian regulatory approval for a drug product is not equivalent to FDA approval, and no part of the Russian clinical literature validates or even addresses home compounding from lyophilized powder. The mixing steps in this article come from general pharmaceutical-compounding practice for peptides, not from a Semax-specific clinical protocol. Separately, the mechanistic research base is real and substantial: studies on Semax's effects on BDNF expression in rat basal forebrain ^[7], transcriptional activation of neurotrophins after cerebral ischemia ^[8], gene expression changes in ischemic rat brain tissue ^{[9] [10] [11]}, and even a 2025 paper on Semax acting through the Oprm1 opioid receptor gene to aid spinal cord injury recovery in mice ^[12]. That's a genuinely interesting and fairly deep animal-and-mechanism literature. It is not the same thing as a Western randomized controlled trial in humans, and nobody should treat it that way. For a fuller look at what the evidence does and doesn't show, see semax before and after claims.

How is reconstituted Semax different from pre-made Semax nasal spray?

A pre-made, provider-reviewed nasal spray arrives already mixed, at a stated concentration, from a facility that controls sterility and potency as part of its normal process. You spray it. There's no math, no syringe, no swirling, no judgment call about whether the vial looks cloudy. A reconstituted-at-home solution depends on the accuracy of your dilution math, the sterility of your technique, the quality of your diluent, and, most importantly, the legitimacy of the powder you started with. Even a perfectly executed reconstitution can't verify what's actually in the vial; that requires third-party testing most home users never do and most vendors don't provide in a trustworthy form. The practical tradeoff is cost and control versus certainty. Powder is usually cheaper per milligram. A provider-reviewed spray costs more but removes the sourcing question and the mixing-error question at once. For a breakdown of what each route actually costs, see semax cost and pricing.

What safety considerations apply specifically to nasal administration?

The nasal route is central to why Semax is studied at all: intranasal delivery lets a peptide reach the central nervous system relatively directly, bypassing first-pass liver metabolism, which is likely part of why the Russian nootropic and analgesic effects literature specifically compared different routes of administration and found notable differences between them ^[13]. But that same direct route means anything wrong with the solution, contamination, wrong concentration, particulate matter, has a faster and more direct path than an oral dose would. Repeated nasal irritation, dryness, or a burning sensation on spray can happen even with correctly mixed solution; this is a mechanical and osmotic tolerability issue, not necessarily a sign of contamination. If irritation is severe, persistent, or accompanied by nasal discharge suggesting infection, stop use. For broader safety questions beyond the reconstitution step itself, including who should avoid Semax and what interactions to consider, see is semax safe and semax drug interactions. For what's actually known and not known about using Semax for months or years, see semax long term side effects.

What tools or calculators help avoid mixing mistakes?

A simple peptide reconstitution calculator (widely available online, not Semax-specific) takes three inputs: powder amount in mg, diluent volume in mL, and desired dose in mg or mcg, then tells you how many mL or how many spray actuations to use. These are generic dilution-math tools, not validated medical devices, so treat the output as a math check, not a clinical recommendation. Write your concentration on the bottle with a permanent marker the moment you finish mixing. It sounds obvious. People still forget which vial is 0.1% and which is 1% after a few weeks in the fridge, and that mixup is a real way to accidentally take a 10x dose.

Frequently asked questions

How much bacteriostatic water do I mix with Semax powder?

It depends on your target concentration and how much powder is in the vial. For a 30 mg vial, 3 mL of diluent gives a 1% solution (10 mg/mL), while 30 mL gives a 0.1% solution (1 mg/mL). Calculate the ratio from your specific vial's labeled content before mixing; don't guess.

Can I use saline instead of bacteriostatic water to reconstitute Semax?

Yes, sterile saline is chemically workable and some people prefer it for nasal comfort since it's isotonic with mucosal tissue. It lacks the antimicrobial preservative in bacteriostatic water, though, so a saline-mixed solution should be used sooner and stored more carefully against contamination.

Do I need to refrigerate Semax after reconstituting it?

Refrigeration is the safer default for any reconstituted peptide, since cold slows both microbial growth and chemical degradation. There's no Semax-specific shelf-stability study confirming an exact safe window at room temperature, so refrigerating and using the solution within a reasonably short window is the cautious approach.

Is it dangerous to shake Semax powder and diluent instead of swirling?

Vigorous shaking can introduce air and mechanical stress that some peptides tolerate poorly, potentially degrading the molecule at the air-liquid interface. There's no dedicated Semax study on this, but general peptide-handling practice recommends gentle swirling or rolling the vial between your palms instead of shaking.

How do I know what concentration my Semax solution is after mixing?

Divide the milligrams of powder in the vial by the milliliters of diluent you added. Thirty milligrams of powder in 3 mL gives 10 mg/mL, a 1% solution. Write the resulting concentration directly on the bottle immediately after mixing so you don't lose track later.

Can reconstituted Semax go bad or get contaminated?

Yes. Watch for cloudiness, particles, discoloration, or an off smell developing after mixing, all signs to discard the solution. Contamination risk comes mainly from non-sterile technique, non-sterile diluent, or repeated pump use introducing bacteria over weeks of storage.

Is Semax FDA approved in the United States?

No. Semax does not appear in Drugs@FDA, the FDA's database of approved drug products. It is also absent from the FDA's 503A and 503B bulk drug substance lists that govern what compounding pharmacies may legally use, meaning it sits outside the standard U.S. regulatory framework for approved or compoundable drugs.

Is Russian approval of Semax the same as FDA approval?

No, and this distinction matters. Semax has a long history as a manufactured pharmaceutical product studied and used in Russian clinical practice, including stroke recovery research published in Russian neurology journals. That regulatory status in Russia does not carry over to the U.S., where Semax has no FDA approval and no bulk-substance listing for compounding.

What syringe size should I use to reconstitute Semax?

A 1 mL or 3 mL syringe with a fine needle works for most small vials, giving precise control over the diluent volume you draw and inject. Match syringe size roughly to your total diluent volume so you're not repeatedly refilling a tiny syringe or eyeballing a partial fill on an oversized one.

Why does the reconstituted solution look cloudy right after mixing?

Cloudiness right after mixing usually just means the powder hasn't fully dissolved yet. Give it more time, swirl gently rather than shake, and check again in a few minutes. If cloudiness appears later, days or weeks into storage, that suggests contamination or degradation and the solution should be discarded.

Can I skip reconstitution entirely by buying pre-made Semax spray?

Yes, and it removes the sterility and dilution-math risk entirely. A provider-reviewed nasal spray arrives already mixed at a stated concentration from a source controlling sterility and potency as part of standard process, at a higher cost per dose than raw powder but without the reconstitution steps or sourcing uncertainty.

Does the route of administration affect how Semax works?

Yes. Research comparing different administration routes found notable differences in Semax's nootropic and analgesic effects depending on route, which is part of why intranasal delivery specifically is used in the Russian clinical and research literature rather than oral or injectable forms.

Sources

1. PubMed, Doklady Biological Sciences (2020), PMID 32342318: Semax is studied as a manufactured intranasal solution with functional connectomic effects documented in Russian research settings
2. PubMed, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2018), PMID 29798983: A 2018 Russian study reported on Semax efficacy in treating patients at different stages of ischemic stroke
3. PubMed, Journal of Neurochemistry (2006), PMID 16635254: Semax binds specifically and increases BDNF protein levels in rat basal forebrain
4. PubMed, Cellular and Molecular Neurobiology (2010), PMID 19633950: Semax and Pro-Gly-Pro activate transcription of neurotrophins and their receptor genes after cerebral ischemia
5. PubMed, BMC Genomics (2014), PMID 24661604: Semax affects expression of immune and vascular system genes in rat brain focal ischemia via genome-wide transcriptional analysis
6. PubMed, Molecular Genetics and Genomics (2017), PMID 28255762: Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats
7. FDA, Drugs@FDA database: Semax does not appear as an FDA-approved drug product in the Drugs@FDA database
8. eCFR, 21 CFR 216.23 (503A Bulks List): Semax is not on the FDA's 503A bulk drug substances list for pharmacy compounding
9. eCFR, 21 CFR 216.24 (503B Bulks List): Semax is not on the FDA's 503B bulk drug substances list for outsourcing facility compounding
10. Cornell Law School Legal Information Institute, 21 U.S.C. 353a: Federal law permits pharmacy compounding from bulk substances only under specific conditions tied to a valid prescription and quality standards
11. PubMed, Genes (2020), PMID 32580520: Semax (ACTH(4-7)PGP) shows protective effects at the transcriptome level following cerebral ischaemia-reperfusion in rats
12. PubMed, British Journal of Pharmacology (2025), PMID 40692165: Semax targets the Oprm1 opioid receptor gene to promote deubiquitination and functional recovery after spinal cord injury in female mice
13. PubMed, Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova (2010), PMID 21268834: Nootropic and analgesic effects of Semax differ depending on the route of administration used